期刊文献+

中国四个项目地区耐多药肺结核患者筛查率、检出率与发现及时性的比较 被引量:13

Case finding of multidrug-resistant tuberculosis through PPM-DOTS in 4 sites in China
下载PDF
导出
摘要 目的分析医院和疾病预防控制系统(简称"医防")合作模式下耐多药肺结核患者发现情况,为耐多药肺结核患者发现提供政策建议。方法收集整理中国疾病预防控制中心结核病预防控制中心与比尔及梅琳达·盖茨基金会合作项目在2011—2012年实施1年期间4个项目地区(开封市、连云港市、重庆市永川区、呼和浩特市)耐多药肺结核可疑者筛查的常规记录,使用筛查率、检出率和发现时间间隔等指标,评价耐多药肺结核患者的发现情况。4个项目地区登记涂阳肺结核患者共2816例,接受快速耐药筛查2365例,其中开封市774例、连云港市761例、重庆市永川区700例、呼和浩特市581例;有完整发现时间信息的来源于结核病防治(简称"结防")机构的涂阳肺结核患者1608例。使用Kruskal-Wallis H秩和检验对4个项目地区的发现情况进行组间比较,显著性水平设定为α=0.05。结果项目地区涂阳肺结核患者总体筛查率为83.98%(2365/2816);使用快速诊断技术耐多药肺结核患者检出率为6.22%(147/2365)。4个项目地区结防机构来源患者发现时间间隔的中位数为7 d,送痰、快速诊断和反馈时间间隔的中位数分别为2、5和0 d。开封市、连云港市、重庆市永川区和呼和浩特市结防机构来源的耐多药肺结核患者发现时间间隔的中位数分别为6、7、9和14 d(H=275.19,P<0.001);送痰时间间隔的中位数分别为1、2、2和2 d(H=104.92,P<0.001);快速诊断时间间隔的中位数分别为5、4、5和6 d(H=8.19,P=0.042);反馈时间间隔的中位数分别为0、0、0和5 d(H=580.32,P<0.001)。结论在医防合作模式下使用快速诊断技术对所有涂阳肺结核患者进行筛查,筛查率较高,检出率处于比较理想的水平,并且患者发现较为及时,这种发现方式是值得借鉴推广的。 Objective To analyze the effect of PPM-DOTS(public TB control institution-public hospital mix for DOTS, PPM-DOTS) in case finding of multidrug-resistant tuberculosis (MDR-TB) cases and to explore the suitable strategy for MDR-TB case finding. Methods The routine records for screening suspected MDR-TB patients in 2011 to 2012 were collected. Screening rate, detection rate and diagnosis time were used to evaluate the effect of PPM-DOTS in MDR-TB case finding. There were 2365 suspected MDR-TB cases detected in four program cities: 774 in Kaifeng, 761 in Lianyungang, 700 in Yongchuan district, Chongqing and 581 in Hohhot; the number for smear positive MDR-TB patients who came from CDC with complete dignosis time was 1608. Kruskal-Wallis H was used to compare the case detection situation in different sites, 0.05 was set as the significance level. Results The overall screening rate in the four sites was 83.98%(2365/2816). The detection rate with rapid test was 6.22%(147/2365). Generally, the medians of diagnosis time, time for sputum transportation, rapid test and information feed-back were 7 d, 2 d, 5 d and 0 d, respectively in four sites. The medians of dignosis time in Kaifeng, Lianyungang, Yongchuan district and Hohhot were 6 d, 7 d, 9 d and 14 d(H=275.19, P〈0.001). The medians of time for sputum transportation were 1 d, 2 d, 2 d and 2 d(H=104.92, P〈0.001), the medians of time for rapid test were 5 d, 4 d, 5 d and 6 d(H=8.19,P=0.042), and the medians of the time for information feed-back were 0 d, 0 d, 0 d and 5 d(H=580.32, P〈0.001). Conclusion The screening rate and detection rate were in good levels, and the MDR-TB patients can be found in time. It is feasible and effective to identify MDR-TB cases by rapid diagnostic method to screen smear positive TB patients in PPM-DOTS settings, and this detection model is worthy learning and expanding.
出处 《中国防痨杂志》 CAS 2013年第12期955-959,共5页 Chinese Journal of Antituberculosis
基金 中国卫生部-比尔及梅琳达.盖茨基金项目(2011CCDC)
关键词 结核 预防和控制 结核 抗多种药物性 预防和控制 普查 Tuberculosis, pulmonary/prevention control Tuberculosis, multidrug-resistant/prevention control Mass screening
  • 相关文献

参考文献10

  • 1World Health Organization. Towards universal access to diag nosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015: WHO progress report 2011 (WHO/HTM/TB/2011.3). Geneva: World Health Or- ganization, 2011. 被引量:1
  • 2World Health Organization. Global tuberculosis control: short update to 2009 report. Geneva: World Health Organization, 2009. 被引量:1
  • 3中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2009:30. 被引量:1
  • 4World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update? (WHO/HTM/TB/2011.6). Geneva: World Health Organi- zation, 2011. 被引量:1
  • 5弭凤玲,王黎霞,李亮,李仁忠,张慧,姜世闻,王笑春,夏洋,陈明亭.中国全球基金耐多药结核病项目阶段性实施结果分析[J].中国防痨杂志,2010,32(11):700-704. 被引量:48
  • 6World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis (WHO/HTM/TB. 2009, 422). 4th ed. Geneva: World Health Organization, 2009. 被引量:1
  • 7World Health Organization. The global plan to stop TB, 2006-2015 (WHO/HTM/STB. 2006.35 ). Geneva.. World Health Organization, 2006. 被引量:1
  • 8徐彩红,李仁忠,赵津,陈明亭,王黎霞.耐多药肺结核患者发现情况分析[J].现代预防医学,2011,38(17):3553-3555. 被引量:14
  • 9Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug resistant tuberculosis: a threat to global con- trol of tuberculosis. Lancet,2010, 375(9728) : 1830-1843. 被引量:1
  • 10黄飞,王黎霞,成诗明,姜世闻,刘小秋.医防合作对提高肺结核患者发现的影响[J].中国防痨杂志,2010,32(7):361-365. 被引量:77

二级参考文献27

  • 1王黎霞,成诗明,徐敏,许卫国,李仁忠,陈松华,黄飞.加强结防机构与医院的合作提高肺结核病人发现试点报告[J].中国防痨杂志,2007,29(6):479-483. 被引量:61
  • 2季明,周余春,孙祖峰.加强医防合作提高肺结核病人发现率[J].江苏预防医学,2005,16(4):47-48. 被引量:5
  • 3马家奇,杨功焕,施晓明.基于IT技术平台的中国疾病监测[J].疾病监测,2006,21(1):1-3. 被引量:75
  • 4Longde Wang, Jianjun Liu, Daniel Chin. Progress in tuberculosis control and the involving public-health system in China[J]. Lancet, 2007, 369:691-696. 被引量:1
  • 5Raviglione M, Uplekar M. WHO's new Stop TB strategy[J]. Lancet, 2006, 367:952-955. 被引量:1
  • 6Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granieh R, Chauhan LS. Improving tuberculosis control through public-private collaboration in India: literature review [J]. BMJ, 2006,332: 574- 578. 被引量:1
  • 7Quy HT, Lan NT, Lonnroth K, Buu TN, Dieu TT. Public-private mix for improved TB control in Ho Chi Minh city, Vietnamtan assessment of its impact on ease detection[J]. Int J Tuberc Lung Dis,2003,7:464--471. 被引量:1
  • 8Newell JN, Pande SB, Baral SC, Bam DS, Malla P. Control of tuberculosis in an urban setting in Nepal:public-private partnership[J]. Bull WHO,2004,82,92-98. 被引量:1
  • 9迟阿鲁 李伟 刘桂生.社区卫生服务背景下医、防机构合作机制的探讨.中国公共卫生管理,2001,17:163-164. 被引量:1
  • 10中国疾病预防控制中心.中国2004年疾病监测统计报告[R]. 被引量:2

共引文献135

同被引文献98

引证文献13

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部